These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34205606)

  • 21. Interactions of amyloid coaggregates with biomolecules and its relevance to neurodegeneration.
    Murakami K; Ono K
    FASEB J; 2022 Sep; 36(9):e22493. PubMed ID: 35971743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of β-amyloid peptide in neurodegenerative diseases.
    Maltsev AV; Bystryak S; Galzitskaya OV
    Ageing Res Rev; 2011 Sep; 10(4):440-52. PubMed ID: 21406255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.
    Soto C; Pritzkow S
    Nat Neurosci; 2018 Oct; 21(10):1332-1340. PubMed ID: 30250260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Heparan sulphates, amyloidosis and neurodegeneration].
    Vera C; Alvarez-Orozco JA; Maiza A; Chantepie S; Chehin RN; Ouidja MO; Papy-Garcia D
    Rev Neurol; 2017 Nov; 65(10):457-468. PubMed ID: 29130469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
    Gerszon J; Rodacka A
    Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When proteostasis goes bad: Protein aggregation in the cell.
    Radwan M; Wood RJ; Sui X; Hatters DM
    IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein aggregation, misfolding and consequential human neurodegenerative diseases.
    Sami N; Rahman S; Kumar V; Zaidi S; Islam A; Ali S; Ahmad F; Hassan MI
    Int J Neurosci; 2017 Nov; 127(11):1047-1057. PubMed ID: 28110595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insight into transglutaminase 2 and link to neurodegenerative diseases.
    Min B; Chung KC
    BMB Rep; 2018 Jan; 51(1):5-13. PubMed ID: 29187283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticle Tracking for Protein Aggregation Research.
    Lu X; Murphy RM
    Methods Mol Biol; 2018; 1777():145-158. PubMed ID: 29744832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanostructural Differentiation and Toxicity of Amyloid-β25-35 Aggregates Ensue from Distinct Secondary Conformation.
    Song Y; Li P; Liu L; Bortolini C; Dong M
    Sci Rep; 2018 Jan; 8(1):765. PubMed ID: 29335442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.
    Longhena F; Spano P; Bellucci A
    Handb Exp Pharmacol; 2018; 245():85-110. PubMed ID: 28965171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualization of prion-like transfer in Huntington's disease models.
    Jansen AH; Batenburg KL; Pecho-Vrieseling E; Reits EA
    Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):793-800. PubMed ID: 28040507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aβ
    Anand BG; Prajapati KP; Kar K
    Biochem Biophys Res Commun; 2018 Jun; 501(1):158-164. PubMed ID: 29723530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species.
    Ruggeri FS; Habchi J; Cerreta A; Dietler G
    Curr Pharm Des; 2016; 22(26):3950-70. PubMed ID: 27189600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural, morphological, and functional diversity of amyloid oligomers.
    Breydo L; Uversky VN
    FEBS Lett; 2015 Sep; 589(19 Pt A):2640-8. PubMed ID: 26188543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules.
    Brahmachari S; Paul A; Segal D; Gazit E
    Future Med Chem; 2017 May; 9(8):797-810. PubMed ID: 28485623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates.
    Ilie IM; Caflisch A
    Chem Rev; 2019 Jun; 119(12):6956-6993. PubMed ID: 30973229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases.
    Som Chaudhury S; Das Mukhopadhyay C
    Int J Neurosci; 2018 May; 128(5):449-463. PubMed ID: 29076790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible, functional amyloids: towards an understanding of their regulation in yeast and humans.
    Cereghetti G; Saad S; Dechant R; Peter M
    Cell Cycle; 2018; 17(13):1545-1558. PubMed ID: 29963943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed α-Synuclein Aggregation.
    Tavassoly O; Sade D; Bera S; Shaham-Niv S; Vocadlo DJ; Gazit E
    J Mol Biol; 2018 Oct; 430(20):3847-3862. PubMed ID: 30098337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.